Jacobs Capital Group Jacobs Capital Group
  • Home
  • Team
  • About Us
  • Portfolio
  • News
  • Contact

No posts were found. Sorry!

Recent Posts

  • HealthCap V Portfolio Company Targovax Completes NOK 200 Private Placement July 10, 2017
  • Final price in BONESUPPORT™’s initial public offering set at SEK 29 per share – trading on Nasdaq Stockholm commences today July 10, 2017
  • CAPIO ACQUIRES A SWEDISH EYE SPECIALIST CLINIC IN STOCKHOLM May 9, 2017
  • Altimmune Completes Merger with PharmAthene Creating Immunotherapeutics Company Targeting Infectious Diseases May 9, 2017
  • HealthCap’s 39th IPO – HealthCap V Company MIPS AB Starts Trading Today on Nasdaq OMX Stockholm March 23, 2017

Archives

  • July 2017
  • May 2017
  • March 2017
  • January 2017
  • October 2016
  • June 2015
  • April 2015
  • October 2011
  • April 2010
  • September 2009

RECENT NEWS

  • HealthCap V Portfolio Company Targovax Completes NOK 200 Private Placement
  • Final price in BONESUPPORT™’s initial public offering set at SEK 29 per share – trading on Nasdaq Stockholm commences today

ABOUT JCG

Jacobs Capital Group is a global fund-of-funds that was established to assist in changing the venture capital model on a global basis and to promote entrepreneurship by building new ventures faster, broader, globally and with less risk.

GET IN TOUCH

Jacobs Capital Group, LLC
670 North Rosemead Blvd
Suite 201 Pasadena, CA 91107

+1 (626) 351-3701

+1 (626) 351-3702

info@jacobscapitalgroup.com

TO BE CONSIDERED

If you would like to submit a Private Placement Memorandum (PPM) or executive summary to be considered for financing, please visit our proprietary deal entry system, MyDealVC.com (beta), and create your personal profile. From there you will be able to enter the PPM, load attachments, and maintain updates.
Designed and Maintained by CS2K